Skip to main content

Table 2 IVF-ET data and clinical outcomes

From: The clinical outcome of Dienogest treatment followed by in vitro fertilization and embryo transfer in infertile women with endometriosis

 

Control (n = 34)

DNG (n = 30)

p

Oocytes retrieved (n)

7.5 ± 4.2

5.0 ± 3.6

P < 0.01

Mature oocytes (n)

6.6 ± 3.9

4.1 ± 3.1

P < 0.01

Fertilized oocytes (n)

5.0 ± 3.2

2.8 ± 2.8

P < 0.01

Fertilization rate (%)

68.0 ± 23.4

53.7 ± 33.0

P < 0.01

Blastocysts (n)

3.9 ± 2.9

1.5 ± 1.7

P < 0.01

Embryos transferred (n)

68

44

 

Gestational sacs (n)

24

11

 

Implantation rate (%)

35.3 (24/68)

25.0 (11/44)

ns

Pregnancy rate (%)

67.6 (23/34)

33.7 (11/30)

P < 0.05

Live birth rate (%)

52.9 (18/34)

23.3 (7/30)

P < 0.05

Abortion rate (%)

25.0 (6/24)

36.4 (4/11)

ns

  1. IVF-ET in vitro fertilization and embryo transfer, DNG dienogest, rASRM revised American society for reproduction medicine, FSH follicle-stimulating hormone, HMG human menopausal gonadotropin